CHIME News

Publication: Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the electronic health records for clinical research (EHR4CR) European project

23 November 2015

In a new paper, Ariel Beresniak and colleagues – including Prof Dipak Kalra of the UCL Institute of Health Informatics – demonstrate the cost savings possible when data from electronic health records are used to perform clinical trials.

They consider three scenarios:

  • protocol feasibility assessment (S1);
  • patient identification for recruitment (S2);
  • clinical study execution (S3).

Should the estimated efficiency gains achieved with the EHR4CR platform translate into faster time-to-market, the expected benefits for the global pharmaceutical oncology sector are estimated at €161.5m (S1), €45.7m (S2), €204.5m (S1 + S2), €1,906m (S3), and up to €2,121.8m (S1 + S2 + S3) when the scenarios are used sequentially.

The paper is available online: Beresniak A, Schmidt A, Proeve J, Bolanos E, Patel N, Ammour N, Sundgren M, Ericson M, Karakoyun T, Coorevits P, Kalra D, De Moor G, Dupont D (2015). Cost-benefit assessment of using electronic health records data for clinical research versus current practices: Contribution of the electronic health records for clinical research (EHR4CR) European project. Contemporary Clinical Trials, online. doi:10.1016/j.cct.2015.11.011

Page last modified on 23 nov 15 11:03